Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Cancer
|
August 1, 1979
Prolonged and continuous percutaneous intra-arterial hepatic infusion chemotherapy in advanced metastatic liver adenocarcinoma from colorectal primary
R A Oberfield, J A McCaffrey, J Polio, et al.
AJR. American Journal of Roentgenology
|
November 1, 1977
Complications of long term transbrachial hepatic arterial infusion chemotherapy
M E Clouse, R Ahmed, R B Ryan, et al.
The American Journal of Medicine
|
April 1, 1976
Clinical usefulness of 67gallium scanning in the malignant lymphomas
J A McCaffrey, R A Rudders, P C Kahn, et al.
Journal of Clinical Gastroenterology
|
June 1, 1991
Flutamide-related fulminant hepatic failure
J C Corkery, W Bihrle, J A McCaffrey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1997
Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival
J A McCaffrey, M Mazumdar, D F Bajorin, et al.
Investigational New Drugs
|
August 25, 2000
Phase II trial of pyrazoloacridine as second-line therapy for patients with unresectable or metastatic transitional cell carcinoma
P M Dodd, J A McCaffrey, M Mazumdar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Phase II trial of docetaxel in patients with advanced or metastatic transitional-cell carcinoma
J A McCaffrey, S Hilton, M Mazumdar, et al.
Irish Journal of Medical Science
|
February 3, 2016
Get the GIST? An overview of gastrointestinal stromal tumours
G A Watson, D Kelly, M Melland-Smith, et al.
Cancer
|
March 26, 1999
Phase II trial of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma
P M Dodd, J A McCaffrey, M Mazumdar, et al.
Cancer Investigation
|
October 19, 2000
Evaluation of drug delivery and survival impact of dose-intense relative to conventional-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy in urothelial cancer
P M Dodd, J A McCaffrey, M Mazumdar, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Cancer
|
August 1, 1979
Prolonged and continuous percutaneous intra-arterial hepatic infusion chemotherapy in advanced metastatic liver adenocarcinoma from colorectal primary
R A Oberfield, J A McCaffrey, J Polio, et al.
AJR. American Journal of Roentgenology
|
November 1, 1977
Complications of long term transbrachial hepatic arterial infusion chemotherapy
M E Clouse, R Ahmed, R B Ryan, et al.
The American Journal of Medicine
|
April 1, 1976
Clinical usefulness of 67gallium scanning in the malignant lymphomas
J A McCaffrey, R A Rudders, P C Kahn, et al.
Journal of Clinical Gastroenterology
|
June 1, 1991
Flutamide-related fulminant hepatic failure
J C Corkery, W Bihrle, J A McCaffrey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1997
Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival
J A McCaffrey, M Mazumdar, D F Bajorin, et al.
Investigational New Drugs
|
August 25, 2000
Phase II trial of pyrazoloacridine as second-line therapy for patients with unresectable or metastatic transitional cell carcinoma
P M Dodd, J A McCaffrey, M Mazumdar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Phase II trial of docetaxel in patients with advanced or metastatic transitional-cell carcinoma
J A McCaffrey, S Hilton, M Mazumdar, et al.
Irish Journal of Medical Science
|
February 3, 2016
Get the GIST? An overview of gastrointestinal stromal tumours
G A Watson, D Kelly, M Melland-Smith, et al.
Cancer
|
March 26, 1999
Phase II trial of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma
P M Dodd, J A McCaffrey, M Mazumdar, et al.
Cancer Investigation
|
October 19, 2000
Evaluation of drug delivery and survival impact of dose-intense relative to conventional-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy in urothelial cancer
P M Dodd, J A McCaffrey, M Mazumdar, et al.
Page
of 3